IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MERONI, MARICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.307
NA - Nord America 3.015
EU - Europa 2.551
SA - Sud America 288
AF - Africa 83
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 9.280
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.928
CN - Cina 1.315
SG - Singapore 779
GB - Regno Unito 728
IT - Italia 462
DE - Germania 345
HK - Hong Kong 307
BR - Brasile 239
SE - Svezia 209
IN - India 169
KR - Corea 162
RU - Federazione Russa 161
JP - Giappone 125
IE - Irlanda 105
FR - Francia 99
NL - Olanda 90
FI - Finlandia 80
VN - Vietnam 75
ID - Indonesia 68
DK - Danimarca 63
IR - Iran 63
CA - Canada 52
TW - Taiwan 51
TR - Turchia 43
BE - Belgio 37
AU - Australia 33
ES - Italia 33
ZA - Sudafrica 27
MX - Messico 26
PL - Polonia 23
AR - Argentina 20
AT - Austria 20
CI - Costa d'Avorio 18
BD - Bangladesh 17
CH - Svizzera 17
EG - Egitto 16
IL - Israele 16
MO - Macao, regione amministrativa speciale della Cina 16
RO - Romania 16
GR - Grecia 12
PK - Pakistan 12
UA - Ucraina 12
PH - Filippine 11
UZ - Uzbekistan 10
KE - Kenya 9
IQ - Iraq 8
TH - Thailandia 8
EC - Ecuador 7
HU - Ungheria 7
MY - Malesia 7
CL - Cile 6
PT - Portogallo 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
NO - Norvegia 5
RS - Serbia 5
AZ - Azerbaigian 4
JO - Giordania 4
PY - Paraguay 4
SY - Repubblica araba siriana 4
AM - Armenia 3
CZ - Repubblica Ceca 3
HR - Croazia 3
KG - Kirghizistan 3
MA - Marocco 3
OM - Oman 3
PA - Panama 3
QA - Qatar 3
SA - Arabia Saudita 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BT - Bhutan 2
CV - Capo Verde 2
CY - Cipro 2
ET - Etiopia 2
HN - Honduras 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LV - Lettonia 2
SI - Slovenia 2
TN - Tunisia 2
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
GY - Guiana 1
KW - Kuwait 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
MM - Myanmar 1
MU - Mauritius 1
NP - Nepal 1
PE - Perù 1
Totale 9.275
Salva come PNG Salva come JPEG
Città #
Southend 611
Singapore 452
Ashburn 384
Hong Kong 241
Dallas 239
Fairfield 219
Beijing 196
Milan 180
Frankfurt am Main 164
Chandler 163
Wilmington 123
Dublin 100
Houston 89
Ann Arbor 88
Seattle 88
Cambridge 84
Santa Clara 83
Woodbridge 82
Shanghai 81
Council Bluffs 80
Hangzhou 78
Princeton 76
Jakarta 64
Nanjing 63
Guangzhou 60
Los Angeles 60
Munich 60
Hefei 53
Bengaluru 49
Redwood City 48
Helsinki 47
Phoenix 44
The Dalles 44
Seoul 40
Dearborn 38
New York 36
Tokyo 35
Moscow 32
São Paulo 32
Buffalo 30
Columbus 30
Shenyang 29
Changsha 28
Central 27
Taipei 26
Cangzhou 24
Chicago 23
Rome 23
Des Moines 22
London 21
New Delhi 21
Tianjin 21
Nuremberg 20
Toronto 20
Chengdu 19
Abidjan 18
Istanbul 18
Wuhan 18
Brussels 17
Delhi 16
Fuzhou 15
Ho Chi Minh City 15
Jinan 15
Boardman 14
Dong Ket 14
Macao 14
San Diego 14
Amsterdam 13
Goyang-si 12
Silver Spring 12
Tehran 12
Lucknow 11
San Jose 11
Vienna 11
Berlin 10
Buk-gu 10
Hanoi 10
Indianapolis 10
Montreal 10
Xian 10
Brooklyn 9
Duncan 9
Düsseldorf 9
Falls Church 9
Johannesburg 9
Kolkata 9
Lappeenranta 9
Ningbo 9
Suzhou 9
Sydney 9
Taichung 9
Ankara 8
Bari 8
Belo Horizonte 8
Central District 8
Chongqing 8
Dhaka 8
Manila 8
Osaka 8
Piscataway 8
Totale 5.591
Salva come PNG Salva come JPEG
Nome #
Recreating gut-liver axis during NAFLD onset by using a Caco-2/HepG2 co-culture system 722
The role of insulin resistance in nonalcoholic steatohepatitis and liver disease development : a potential therapeutic target? 551
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals 398
DOWN-REGULATION OF HEPATIC MBOAT7 BY HYPERINSULINEMIA FAVORS STEATOSIS DEVELOPMENT 359
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent 300
Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease 293
MAFLD in COVID-19 patients: an insidious enemy 282
Genetic and metabolic factors: the perfect combination to treat metabolic associated fatty liver disease 264
TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models 262
β-Klotho gene variation is associated with liver damage in children with NAFLD 260
Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker 251
The rs2294918 E434K variant modulates PNPLA3 expression and liver damage 246
PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients 235
PNPLA3 overexpression results in reduction of proteins predisposing to fibrosis 232
MBOAT7 down-regulation by genetic and environmental factors predisposes to MAFLD 213
Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease 212
Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in nonalcoholic fatty liver disease 194
Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis 191
Liver fat accumulation is associated with circulating PCSK9 189
Expanding the phenotypic spectrum of non-alcoholic fatty liver disease and hypertriglyceridemia 179
Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes: Mboat7 reduction and hepatic steatosis 179
MiRNA signature in NAFLD: A turning point for a non-invasive diagnosis 173
Impact of natural neuromedin-B receptor variants on iron metabolism 157
Notch signaling and progenitor/ductular reaction in steatohepatitis 146
Alcohol or gut microbiota : who is the guilty? 142
Recent advances of drugs monitoring in oral fluid and comparison with blood 140
Salivary biomarkers: novel noninvasive tools to diagnose chronic inflammation 139
$\upalpha$-Lipoic Acid Improves Hepatic Metabolic Dysfunctions in Acute Intermittent Porphyria: A Proof-of-Concept Study [alpha-Lipoic Acid Improves Hepatic Metabolic Dysfunctions in Acute Intermittent Porphyria: A Proof-of-Concept Study] 137
{PD}-1/{PD}-L1 Immuno-Mediated Therapy in {NAFLD}: Advantages and Obstacles in the Treatment of Advanced Disease 132
Fibronectin type III domain-containing protein 5 rs3480 A>G polymorphism, irisin, and liver fibrosis in patients with Nonalcoholic fatty liver disease 130
Nutrition and genetics in NAFLD : The perfect binomium 130
Neurotensin up-regulation is associated with advanced fibrosis and hepatocellular carcinoma in patients with MAFLD 130
From Environment to Genome and Back : a Lesson from HFE Mutations 125
Circulating indian hedgehog is a marker of the hepatocyte-TAZ pathway in experimental NASH and is elevated in humans with NASH 121
An Overview of Hepatocellular Carcinoma Surveillance Focusing on Non-Cirrhotic NAFLD Patients: A Challenge for Physicians 120
The rs599839 a>g variant disentangles cardiovascular risk and hepatocellular carcinoma in nafld patients 119
The α-Lipoic Acid Improves Hepatic Metabolic Dysfunctions in Acute Intermittent Porphyria: A Proof-of-Concept Study 118
Impact of Sarcopenia and Myosteatosis in Non-Cirrhotic Stages of Liver Diseases: Similarities and Differences across Aetiologies and Possible Therapeutic Strategies 118
Mitochondrial dynamics and nonalcoholic fatty liver disease (NAFLD): new perspectives for a fairy-tale ending? 116
Mir-101-3p downregulation promotes fibrogenesis by facilitating hepatic stellate cell transdifferentiation during insulin resistance 113
Genetics is of the essence to face NAFLD 107
The role of probiotics in nonalcoholic fatty liver disease : A new insight into therapeutic strategies 105
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores 105
Notch-mediated hepatocyte MCP-1 secretion causes liver fibrosis 100
The I148M PNPLA3 variant mitigates niacin beneficial effects: How the genetic screening in non-alcoholic fatty liver disease patients gains value 99
Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease 97
Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis 89
Hepatic IRF3 fuels dysglycemia in obesity through direct regulation of Ppp2r1b 78
Corrigendum to: "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort" [J Hepatol (2020) 505-515] 74
MAFLD definition underestimates the risk to develop HCC in genetically predisposed patients 70
Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically-characterised cohort 58
Next Generation Sequencing Allows Identification of a Novel Mutation in the TfR2 Gene and Outperforms the Conventional Diagnostic Techniques 54
Exploring multiorgan mitochondrial dysfunction in the switch toward progressive MASLD in AMLN mice 7
null 3
Totale 9.564
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.261
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.261
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021627 0 0 0 0 0 96 74 77 89 123 90 78
2021/2022910 75 63 56 89 49 54 50 90 92 61 104 127
2022/2023990 82 83 90 77 97 169 29 86 139 22 69 47
2023/2024982 43 93 71 85 179 78 86 50 42 44 87 124
2024/20252.102 122 229 67 210 157 86 137 195 125 190 207 377
2025/20261.913 415 293 497 299 375 34 0 0 0 0 0 0
Totale 9.564